296 related articles for article (PubMed ID: 28490271)
21. Association between diet-related inflammation, all-cause, all-cancer, and cardiovascular disease mortality, with special focus on prediabetics: findings from NHANES III.
Deng FE; Shivappa N; Tang Y; Mann JR; Hebert JR
Eur J Nutr; 2017 Apr; 56(3):1085-1093. PubMed ID: 26825592
[TBL] [Abstract][Full Text] [Related]
22. Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease events.
Wong ND; Gransar H; Shaw L; Polk D; Moon JH; Miranda-Peats R; Hayes SW; Thomson LE; Rozanski A; Friedman JD; Berman DS
JACC Cardiovasc Imaging; 2009 Mar; 2(3):319-26. PubMed ID: 19356578
[TBL] [Abstract][Full Text] [Related]
23. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
24. Predictive modeling using a nationally representative database to identify patients at risk of developing microalbuminuria.
Villa-Zapata L; Warholak T; Slack M; Malone D; Murcko A; Runger G; Levengood M
Int Urol Nephrol; 2016 Feb; 48(2):249-56. PubMed ID: 26661258
[TBL] [Abstract][Full Text] [Related]
25. Impact of Treating Oral Disease on Preventing Vascular Diseases: A Model-Based Cost-effectiveness Analysis of Periodontal Treatment Among Patients With Type 2 Diabetes.
Choi SE; Sima C; Pandya A
Diabetes Care; 2020 Mar; 43(3):563-571. PubMed ID: 31882408
[TBL] [Abstract][Full Text] [Related]
26. Do the 2017 blood pressure cut-offs improve 10-year cardiovascular disease mortality risk prediction?
Peng Y; Wang Z
Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2008-2016. PubMed ID: 32723581
[TBL] [Abstract][Full Text] [Related]
27. Predicting life span of type 2 diabetes patients through alkaline phosphatase and vitamin D: Results from NHANES 1999-2018.
Yang F; Wang M; Du J; Fu Y; Deng J; Wu J; Zhang Y; Li Y
Atherosclerosis; 2024 Jul; 394():117318. PubMed ID: 37839936
[TBL] [Abstract][Full Text] [Related]
28. Homocysteine and reclassification of cardiovascular disease risk.
Veeranna V; Zalawadiya SK; Niraj A; Pradhan J; Ference B; Burack RC; Jacob S; Afonso L
J Am Coll Cardiol; 2011 Aug; 58(10):1025-33. PubMed ID: 21867837
[TBL] [Abstract][Full Text] [Related]
29. Prospective association of periodontal disease with cardiovascular and all-cause mortality: NHANES III follow-up study.
Xu F; Lu B
Atherosclerosis; 2011 Oct; 218(2):536-42. PubMed ID: 21831372
[TBL] [Abstract][Full Text] [Related]
30. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
32. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.
Sánchez-Romero LM; Penko J; Coxson PG; Fernández A; Mason A; Moran AE; Ávila-Burgos L; Odden M; Barquera S; Bibbins-Domingo K
PLoS Med; 2016 Nov; 13(11):e1002158. PubMed ID: 27802278
[TBL] [Abstract][Full Text] [Related]
33. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a County-Level Social Determinants of Health Risk Assessment Tool for Cardiovascular Disease.
Hong YR; Mainous AG
Ann Fam Med; 2020 Jul; 18(4):318-325. PubMed ID: 32661032
[TBL] [Abstract][Full Text] [Related]
35. Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study.
Nelson MR; Ryan P; Tonkin AM; Ramsay E; Willson K; Wing LW; Reid CM;
Hypertension; 2010 Jul; 56(1):44-8. PubMed ID: 20497992
[TBL] [Abstract][Full Text] [Related]
36. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
37. Alternative Strategies to Achieve Cardiovascular Mortality Goals in China and India: A Microsimulation of Target- Versus Risk-Based Blood Pressure Treatment.
Basu S; Yudkin JS; Sussman JB; Millett C; Hayward RA
Circulation; 2016 Mar; 133(9):840-8. PubMed ID: 26762520
[TBL] [Abstract][Full Text] [Related]
38. Room for depressed and exhausted mood as a risk predictor for all-cause and cardiovascular mortality beyond the contribution of the classical somatic risk factors in men.
Ladwig KH; Baumert J; Marten-Mittag B; Lukaschek K; Johar H; Fang X; Ronel J; Meisinger C; Peters A;
Atherosclerosis; 2017 Feb; 257():224-231. PubMed ID: 28110940
[TBL] [Abstract][Full Text] [Related]
39. A comparative assessment of non-laboratory-based versus commonly used laboratory-based cardiovascular disease risk scores in the NHANES III population.
Pandya A; Weinstein MC; Gaziano TA
PLoS One; 2011; 6(5):e20416. PubMed ID: 21655241
[TBL] [Abstract][Full Text] [Related]
40. Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort.
Mannino DM; Davis KJ; Disantostefano RL
Respirology; 2013 Oct; 18(7):1083-8. PubMed ID: 23683308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
